VAM
LSB

Valliance Asset Management’s LakeShore Biopharma LSB Stock Holding History

Valliance Asset Management’s Portfolio LSB Stock Details LSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-160,718
Closed -$821K – 12
2023
Q4 		$821K Hold
160,718
– – 29.03% 2
2023
Q3 		$1.29M Hold
160,718
– – 4.68% 7
2023
Q2 		$2.22M Hold
160,718
– – 35.42% 2
2023
Q1 		$2.57M Buy
+160,718
New +$8.14M 4.59% 5

Other funds holding LSB

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $245B AUM 31.4% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
Pinpoint Asset Management Hong Kong $576M AUM 43.65% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $6.41B AUM 4.78% 1-Year Est. Return